life sciences

Life Sciences Arbitration

Life Sciences Arbitration

CRA’s life sciences arbitration support is grounded in a comprehensive, insiders’ understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 25 years, we have consulted directly with major life science companies, law firms, and regulatory agencies around the globe. This deep industry knowledge is complemented by our extensive experience in complex litigation. CRA’s involvement has helped our clients solve their most challenging strategic problems and resolve their most contentious disputes.


  • 01
    Breach of a global co-marketing deal: Swiss arbitration
    Situation: Our client, a major pharmaceutical manufacturer, had to prove damages from the wrongful termination of its global co-marketing/co-promotion rights...
    View engagement
  • 02
    AAA arbitration regarding breach of purchase agreement
    CRA was retained by the claimant in a dispute at AAA alleging breach of a purchase agreement due to the respondent’s alleged failure to make contracted minimum...
    View engagement
  • 03
    AAA arbitration regarding medical device licensing agreement
    In AAA arbitration, CRA was retained by respondent regarding the interpretation of commercial terms in a licensing agreement related to medical devices.  CRA...
    View engagement

Related Capabilities

Subscribe to receive our latest Insights.